Targeted Clinical Research Program to Address Selected Viral Infections

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients and includes a Phase II clinical trial.